Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Metabolic Syndrome in Iran: A 2011 Update Publisher Pubmed



Noshad S1 ; Abbasi M1 ; Etemad K3 ; Meysamie A2 ; Afarideh M1 ; Khajeh E1 ; Asgari F3 ; Mousavizadeh M1 ; Rafei A3 ; Neishaboury M1 ; Ghajar A1 ; Nakhjavani M1 ; Koohpayehzadeh J3 ; Esteghamati A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran, Iran
  2. 2. Department of Preventive Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Centers for Disease Control and Prevention, Tehran, Iran

Source: Journal of Diabetes Published:2017


Abstract

Background: The aim of the present study was to determine the prevalence of metabolic syndrome and its individual components among the Iranian adult population in 2011 and to investigate changes between 2007 and 2011. Methods: Data from two rounds of the Surveillance of Risk Factors of Non-communicable Diseases national surveys conducted in 2007 and 2011 were pooled. Metabolic syndrome was defined according to International Diabetes Federation criteria. Results: In 2007, the prevalence of metabolic syndrome among adults aged 25–64 years was 35.95 (95% confidence interval [CI] 34.27–37.63), which decreased to 32.96 (95% CI 30.73–35.18) in 2011 (P = 0.0108). Despite this overall decline, the prevalence of central obesity (P = 0.1383), raised triglycerides (P = 0.3058), and reduced high-density lipoprotein cholesterol (HDL-C; P = 0.5595) remained constant. There was a trend towards a decline in the proportion of individuals with increased blood pressure (P = 0.0978), and the proportion of adults with increased fasting plasma glucose (FPG) increased (P < 0.0001). In 2011, the prevalence of central obesity, raised triglycerides, reduced HDL-C, increased blood pressure and increased FPG was 51.88 (95% CI 48.97–54.79), 36.99 (95% CI 34.52–39.45), 54.72 (95% CI 50.87–58.57), 38.92 (95% CI 36.19–41.64), and 24.97 (95% CI 22.02–27.93) respectively. Conclusions: Over the period 2007–11, the prevalence of metabolic syndrome has decreased slightly in Iran, although prevalence of increased FPG has increased significantly. One-third of the Iranian adult population is diagnosed with metabolic syndrome. © 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
Related Docs
View other Related Docs
1. Association of Low Vitamin D Levels With Metabolic Syndrome in Hemodialysis Patients, Hemodialysis International (2016)
2. Age and Gender Differences in the Clustering of Metabolic Syndrome Combinations: A Prospective Cohort Research From the Kerman Coronary Artery Disease Risk Study (Kercadrs), Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
3. The Clinical Value of Metabolic Syndrome and Its Components With Respect to Sudden Cardiac Death Using Different Definitions: Two Decades of Follow-Up From the Tehran Lipid and Glucose Study, Cardiovascular Diabetology (2022)
4. An Interactive Web-Based Intervention on Nutritional Status, Physical Activity and Health-Related Quality of Life in Patient With Metabolic Syndrome: A Randomized-Controlled Trial (The Red Ruby Study), Nutrition and Diabetes (2017)
5. Effect of Long-Term Exposure to Ambient Particulate Matter on Prevalence of Type 2 Diabetes and Hypertension in Iranian Adults: An Ecologic Study, Environmental Science and Pollution Research (2018)
6. The Association Between Smoking and Obesity in Iranian Adult Population: A Study Based on Third National Surveillance of the Risk Factors of the Noncummunicable Diseases (Surfncd-2007), Journal of Experimental and Clinical Medicine (Turkey) (2017)
7. Metabolic Syndrome and Lifestyle-Associated Factors in the Ethnically Diverse Population of Khuzestan, Iran: A Cross-Sectional Study, Journal of Diabetes and Metabolic Disorders (2021)
8. National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the Surfncd-2011, Global Heart (2018)
Experts (# of related papers)
View all Related Experts
Alireza Esteghamati (10)
Farshad Farzadfar (9)
Other Related Docs
9. A Nationwide Study of Metabolic Syndrome Prevalence in Iran; a Comparative Analysis of Six Definitions, PLoS ONE (2021)
10. Association Between Metabolic Syndrome and Job Rank, International Journal of Occupational and Environmental Medicine (2018)
11. Breast Cancer Incidence Trends in Golestan, Iran: An Age-Period-Cohort Analysis by Ethnic Region, 2004-2018, Cancer Epidemiology (2024)
12. Adiponectin: An Indicator for Metabolic Syndrome, Iranian Journal of Public Health (2019)
13. White Rice Intake and Incidence of Type-2 Diabetes: Analysis of Two Prospective Cohort Studies From Iran, BMC Public Health (2017)
14. Prevalence of Tobacco Use in Adults; 2016 Nationally Representative Household Survey in Iran, International Journal of Preventive Medicine (2022)
15. Is Incident Type 2 Diabetes Associated With Cumulative Excess Weight and Abdominal Adiposity? Tehran Lipid and Glucose Study, Diabetes Research and Clinical Practice (2018)
16. The Association Between Metabolic Syndrome and Major Adverse Cardiac and Cerebrovascular Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention, Scientific Reports (2024)
17. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
18. Diabetes Care in Iran: Where We Stand and Where We Are Headed, Annals of Global Health (2015)
19. A Web-Based Interactive Lifestyle Modification Program Improves Lipid Profile and Serum Adiponectin Concentrations in Patients With Metabolic Syndrome: The “Red Ruby” Study, International Journal of Diabetes in Developing Countries (2017)
20. Zero and Five End-Digit Preference and Blood Pressure Quality of Care Revisited, Archives of Iranian Medicine (2017)
21. High Incidence of Diabetes Mellitus Among a Middle-Aged Population in Iran: A Longitudinal Study, Canadian Journal of Diabetes (2016)
22. Diabetes Mellitus and Its Risk Factors Among a Middle-Aged Population of Iran, a Population-Based Study, International Journal of Diabetes in Developing Countries (2016)
23. Dietary Consumption of Advanced Glycation End Products and Risk of Metabolic Syndrome, International Journal of Food Sciences and Nutrition (2016)
24. Colorectal Cancer Incidence Trends in Golestan, Iran: An Age-Period-Cohort Analysis 2004–2018, Cancer Epidemiology (2023)
25. The Relationship Between Functional Constipation and Major Dietary Patterns in Iranian Adults: Findings From the Large Cross-Sectional Population-Based Sepahan Study, Preventive Nutrition and Food Science (2021)
26. Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review, Frontiers in Pharmacology (2018)
27. Association of Plant-Based Diets With Adropin, Atherogenic Index of Plasma, and Metabolic Syndrome and Its Components: A Cross-Sectional Study on Adults, Frontiers in Nutrition (2023)
28. Revising the Fasting Glucose Threshold for Detection of Cardiovascular Risk Factors: Analysing Two Representative Population-Based Studies of More Than 50000 Iranians in 3 Years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran, Annals of Human Biology (2015)
29. A Posteriori Dietary Patterns and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis of Observational Studies, Public Health Nutrition (2018)
30. A Systematic Review of Studies on Blood Pressure in Iranian Pediatric Population: First Report From the Middle East and North Africa, Iranian Journal of Pediatrics (2016)
31. Food Insecurity Is an Important Risk Factor for Type 2 Diabetes: A Case-Control Study of New Referrals to the University Clinics, Shiraz, Southern Iran, BMC Public Health (2019)
32. Trend and Pattern of Using Herbal Medicines Among People Who Are Aware of Their Diabetes Mellitus: Results From National Steps Surveys in 2005 to 2011 in Iran, Journal of Diabetes and Metabolic Disorders (2021)
33. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study, Thyroid (2017)
34. Informal Caregivers in Hospitals: Opportunities and Threats, International Journal of Health Planning and Management (2018)
35. Taq1b Polymorphism of Cholesteryl Ester Transfer Protein (Cetp) and Its Effects on the Serum Lipid Levels in Metabolic Syndrome Patients, Biochemical Genetics (2016)
36. The Effects of Resveratrol Supplementation in Patients With Type 2 Diabetes, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials, American Journal of Clinical Nutrition (2021)
37. Prediction of Metabolic Syndrome Based on Sleep and Work-Related Risk Factors Using an Artificial Neural Network, BMC Endocrine Disorders (2020)
38. Evaluation of the Diabetes Care Cascade and Compliance With Who Global Coverage Targets in Iran Based on Steps Survey 2021, Scientific Reports (2023)
39. The Association Between Cyba Gene C242t Variant and Risk of Metabolic Syndrome, European Journal of Clinical Investigation (2020)
40. Association of Neuropeptide Y Gene Rs16147 Polymorphism With Metabolic Syndrome in Patients With Documented Coronary Artery Disease, Annals of Human Biology (2015)
41. Physical Inactivity, Inequalities, and Disparities Across Districts of Iran: A Steps Survey-Based Analysis, Journal of Physical Activity and Health (2023)
42. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes Mellitus Among the Adult Residents of Tehran: Tehran Cohort Study, BMC Endocrine Disorders (2022)
43. The Levels and Trends of Metabolic Risk Factors in the Elderly Population at the National and Sub-National Scale in Iran From 1990 to 2016, Journal of Diabetes and Metabolic Disorders (2023)
44. Incidence of Thyroid Dysfunction Facing Metabolic Syndrome: A Prospective Comparative Study With 9 Years of Follow-Up, European Thyroid Journal (2021)
45. Evaluation of Plasma Mmp-8, Mmp-9 and Timp-1 Identifies Candidate Cardiometabolic Risk Marker in Metabolic Syndrome: Results From Double-Blinded Nested Case-Control Study, Metabolism: Clinical and Experimental (2015)
46. Non-High-Density Lipoprotein Fractions Are Strongly Associated With the Presence of Metabolic Syndrome Independent of Obesity and Diabetes: A Population-Based Study Among Iranian Adults, Journal of Diabetes and Metabolic Disorders (2017)
47. Temporal Trends in Cardiovascular Disease Risk Factors Attributed Burden in Iran, 1990–2021, Scientific Reports (2025)
48. The Prevalence of Metabolic Syndrome and Different Obesity Phenotype in Iranian Male Military Personnel, American Journal of Men's Health (2017)
49. Comparison of the Prevalence of Metabolic Syndrome in Military and Non-Military (Civilian) Personnel and Its Relationship With Lifestyle, Journal of Military Medicine (2021)
50. The Effect of a Cognitive Behavioral Program Based on an Interactive Application on Serum Glucose Levels and Hba1c of Family Members of Patients With Type 2 Diabetes: A Study Protocol for a Randomized Clinical Trial, Journal of Diabetes and Metabolic Disorders (2023)